Literature DB >> 17406299

Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles.

James T Koerber1, Narendra Maheshri, Brian K Kaspar, David V Schaffer.   

Abstract

Rational design of improved gene delivery vehicles is a challenging and potentially time-consuming process. As an alternative approach, directed evolution can provide a rapid and efficient means for identifying novel proteins with improved function. Here we describe a methodology for generating very large, random adeno-associated viral (AAV) libraries that can be selected for a desired function. First, the AAV2 cap gene is amplified in an error-prone PCR reaction and further diversified through a staggered extension process. The resulting PCR product is then cloned into pSub2 to generate a diverse (>10(6)) AAV2 plasmid library. Finally, the AAV2 plasmid library is used to package a diverse pool of mutant AAV2 virions, such that particles are composed of a mutant AAV genome surrounded by the capsid proteins encoded in that genome, which can be used for functional screening and evolution. This procedure can be performed in approximately 2 weeks.

Entities:  

Mesh:

Year:  2006        PMID: 17406299     DOI: 10.1038/nprot.2006.93

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  33 in total

1.  Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.

Authors:  Ai-Wu Mao; Ting-Hui Jiang; Xian-Jun Sun; Jian Peng
Journal:  Tumour Biol       Date:  2015-06-05

2.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

3.  Transforming growth factor β receptor signaling restrains growth of pancreatic carcinoma cells.

Authors:  Zhiming Zhao; Hao Xi; Dabin Xu; Chenggang Li
Journal:  Tumour Biol       Date:  2015-05-03

Review 4.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

5.  Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.

Authors:  Marc S Weinberg; Sarah Nicolson; Aadra P Bhatt; Michael McLendon; Chengwen Li; R Jude Samulski
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

6.  A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line.

Authors:  Dawn P Wooley; Priyanka Sharma; John R Weinstein; Poornima Kotha Lakshmi Narayan; David V Schaffer; Katherine J D A Excoffon
Journal:  J Virol Methods       Date:  2017-09-14       Impact factor: 2.014

7.  In vivo-directed evolution of adeno-associated virus in the primate retina.

Authors:  Leah C Byrne; Timothy P Day; Meike Visel; Jennifer A Strazzeri; Cécile Fortuny; Deniz Dalkara; William H Merigan; David V Schaffer; John G Flannery
Journal:  JCI Insight       Date:  2020-05-21

Review 8.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

9.  CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes.

Authors:  Benjamin Steines; David D Dickey; Jamie Bergen; Katherine Jda Excoffon; John R Weinstein; Xiaopeng Li; Ziying Yan; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Linda S Powers; Nicholas D Gansemer; Lynda S Ostedgaard; John F Engelhardt; David A Stoltz; Michael J Welsh; Patrick L Sinn; David V Schaffer; Joseph Zabner
Journal:  JCI Insight       Date:  2016-09-08

10.  Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery.

Authors:  J-H Jang; J T Koerber; K Gujraty; S R Bethi; R S Kane; D V Schaffer
Journal:  Gene Ther       Date:  2010-05-27       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.